Combretastatin A-4 disodium phosphate: A vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotheraphy

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 4, 2001, Pages 1018-1024

  Murata, Rumi ^a   Overgaard, Jens ^a   Horsman, Michael R ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

C3H mouse mammary carcinoma; Combretastatin A 4 disodium phosphate; Mild hyperthermia; Radiation; Vascular targeting

Indexed keywords

BIOASSAY; DRUG PRODUCTS; TISSUE; TUMORS;

THERMAL DAMAGES;

RADIOTHERAPY;

COMBRESTATIN A 4 DISODIUM PHOSPHATE; COMBRETASTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER CONTROL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HYPERTHERMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE; TEMPERATURE; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; COMBINED MODALITY THERAPY; DRUG EVALUATION; FEMALE; HYPERTHERMIA, INDUCED; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; RADIOBIOLOGY; STILBENES; TIME FACTORS;

EID: 0035889331     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01742-4     Document Type: Article

References (38)

1. Tumour vasculature as a target for cancer therapy
2. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumour vasculature
3. The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors
4. Anti-vascular approaches to solid tumour therapy; Evaluation of combretastatin A4 phosphate
5. Combretastatin A-4 phosphate as a tumor vascular-targeting agent; Early effects in tumors and normal tissues
6. Angiogenesis. From molecular to integrative pharmacology
7. Antivascular approaches to solid tumour therapy; Evaluation of tubulin binding agents
8. Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine; Evidence for a vascular mechanism
9. Anti-vascular approaches to solid tumour therapy; Evaluation of vinblastine and flavone acetic acid
10. The in vivo interaction between flavone acetic acid and hyperthermia
11. Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone 4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs
12. The effect of vascular occlusion on the thermal sensitization of a mouse tumour
13. Cell kill and tumor control after heat treatment with and without vascular occlusion in RIF-1 tumors
14. The effects of heat and radiation on cancers implanted on the feet of mice
15. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo
16. Substantial enhancement of tumor hyperthermic response by tumor necrosis factor
17. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSaII tumors
18. A study of the mechanism of hydralazine enhancement of thermal damage in the KHT tumour
19. The influence of hypoxia and acidity on the hyperthermic response of malignant cells in vitro
20. Response of cells to hyperthermia under acute and chronic hypoxic conditions
21. The role of tissue environmental factors on the kinetics and morphology of tumor cells exposed to hyperthermia
22. The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma
23. Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation
24. Rationale and problems in the design of clinical trials
25. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma; A multicentre randomized trial by the European Society for Hyperthermic Oncology
26. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer; Results from five randomized controlled trials
27. The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy
28. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours; A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group
29. Hyperthermic treatment of malignant diseases; Current status and a view toward the future
30. Hyperthermia from the clinic to the laboratory; A hypothesis
31. Hyperthermia in the treatment of cancer
32. Thermal radiosensitization in animal tumors; The potential for therapeutic gain
33. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo
34. Targeting the tumor vasculature with combretastatin A-4 disodium phosphate; Effects on radiation therapy
35. Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues
36. Hyperthermia-induced changes in the vascularity and histopathology of a murine tumour and its surrounding normal tissue
37. The influence of tumour temperature on ischemia-induced cell death; Potential implications for the evaluation of vascular mediated therapies
38. Ischaemia induced cell death in tumors; Importance of temperature and pH